Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;163(6):1144-1149.
doi: 10.1177/0194599820939538. Epub 2020 Jun 30.

Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects

Alberto Paderno  1 , Davide Mattavelli  1 , Vittorio Rampinelli  1 , Alberto Grammatica  1 , Elena Raffetti  2 , Michele Tomasoni  1 , Tommaso Gualtieri  1 , Stefano Taboni  1 , Silvia Zorzi  1 , Francesca Del Bon  1 , Davide Lombardi  1 , Alberto Deganello  1 , Luca Oscar Redaelli De Zinis  1 , Alberto Schreiber  1
Affiliations

Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects

Alberto Paderno et al. Otolaryngol Head Neck Surg. 2020 Dec.

Abstract

Objective: To prospectively assess the rate and timing of recovery of olfactory (OD) and gustatory (GD) dysfunction in patients affected by COVID-19.

Study design: Cohort study.

Setting: Population-based evaluation in a COVID-19 high-prevalence region.

Subjects and methods: We analyzed the clinical course of OD and GD in a cohort of home-quarantined SARS-CoV-2-positive patients from Northern Italy. Physicians administered a survey-based questionnaire at recruitment (T0). During follow-up, patients responded to online dedicated surveys modulated according to symptoms at T0.

Results: A total of 151 patients completed the follow-up survey. OD and/or GD were observed in 83% and 89% of subjects, respectively. Resolution rates of OD and GD at 30 days from onset were 87% and 82%, respectively. Risk factors for late resolution were grade of dysfunction at onset (total vs partial), gender, and presence of nasal congestion. Three (2%) patients previously reporting complete resolution of symptoms complained of subsequent recurrence of OD and/or GD after a mean of 19 days from resolution of the previous episode.

Conclusion: COVID-19-related OD and GD had high rate of resolution in the first month from onset of symptoms. However, in 10% to 15% of patients, these symptoms showed only partial improvement after this period.

Keywords: COVID-19; SARS-CoV-2; gustatory dysfunction; olfactory dysfunction; recovery; smell; taste.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Kaplan-Meier curves showing the recovery pattern of olfactory dysfunction in the entire series (A), according to gender (B), nasal congestion (C), and grade of olfactory dysfunction at presentation (D).
Figure 2.
Figure 2.
Kaplan-Meier curves showing the recovery pattern of gustatory dysfunction in the entire series (A), according to gender (B), nasal congestion (C), and grade of gustatory dysfunction at presentation (D).
See this image and copyright information in PMC

Comment in

References

    1. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020. doi:10.1177/194599820926473. - DOI - PubMed
    1. Sedaghat AR, Gengler I, Speth MM. Olfactory dysfunction: a highly prevalent symptom of COVID-19 with public health significance. Otolaryngol Head Neck Surg. 2020. doi: 10.1177/194599820926464. - DOI - PubMed
    1. Paderno A, Schreiber A, Grammatica A, et al. Smell and taste alterations in Covid-19: a cross-sectional analysis of different cohorts. Int Forum Allergy Rhinol. 2020. doi:10.1002/alr.22610 - DOI - PMC - PubMed
    1. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020. doi:10.1007/s00405-020-05965-1 - DOI - PMC - PubMed
    1. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552-555. doi:10.1002/jmv.25728 - DOI - PMC - PubMed